FN1 and atopic eczema: Additionally, in a human skin xenograft model of atopic dermatitis, IL-4 treatment suppressed FN expression and delayed wound healing, while topical application of exogenous FN reversed this delay and promoted wound closure, alongside restoration of epidermal differentiation complex gene expression [47].